Dalacin C 300 mg tvrde kapsule
| Name | Dalacin C 300 mg tvrde kapsule |
|---|---|
| Marketing Authorisation Number | HR-H-200113413 |
| Active Substance | klindamicinklorid |
| Composition | 1 tvrda kapsula sadrži 300 mg klindamicina u obliku klindamicinklorida |
| Pharmaceutical Form | kapsula, tvrda |
| Manufacturer | Fareva Amboise, Poce-sur-Cisse, Francuska |
| Marketing Authorisation Holder | Pfizer Croatia d.o.o., Slavonska avenija 6, Zagreb, Hrvatska |
| Marketing Authorisation Date | 20.05.2020 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/18-02/73 |
| Registration Number | 381-12-01/38-20-06 |
| Prescription | na recept |
| Type of prescription | neponovljivi recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | J01FF01 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
